Value Added Seminar

Tate & Lyle PLC
                  

Tate & Lyle Value Added Seminar - 20 October 2004

Tate & Lyle PLC will be holding a seminar discussing value added products today
in London commencing at 10.00 am. The meeting will be hosted by Iain Ferguson,
Chief Executive, and other senior managers and will be attended by institutional
investors and stockbrokers' analysts.

Iain Ferguson will provide an overview of our business and value added products
and then Simon Gifford, Group Finance Director, will explain the contribution
that value added products make to overall profitability and the applications for
these products.

Greg Morency, our new global Vice President Marketing, will set out our new
approach to customers. After a break to visit product displays, John Roginski,
Vice President, Sales and Marketing, Industrial Products for Tate & Lyle in the
US, will give an update on bio-products.

Austin Maguire, President of Tate & Lyle Sucralose, will provide an overview on
what is happening in this business, where we now expect sales for the six months
to September 2004 to exceed US$100 million and profit before tax to exceed the
proforma US$33 million achieved in the 2003 calendar year.

The presentations given at the seminar will be available on our website
http://www.tateandlyle.com/TateAndLyle/investor_relations/roadshows/default.htm
following the start of the meeting.

For more information contact:

Mark Robinson, Head of Investor Relations
Tel: [phone] or Mobile: [phone] [e-mail]

Chris Fox, Director of Corporate Relations (Press)
Tel: [phone] or Mobile: [phone]

Tate & Lyle is a world leader in renewable ingredients. Its core competence is
to take corn, wheat or sugar, and add value to these raw materials through
technology. As a result of continuous innovation it offers an ever-wider product
portfolio of versatile and functional ingredients. These products include Cereal
Sweeteners, Starches, Sugars, Citric Acid and SPLENDA® Sucralose. Tate & Lyle
products have wide applications in the food, beverage, pharmaceutical, cosmetic,
paper, packaging and building industries. With headquarters in London, Tate &
Lyle operates more than 41 plants and 20 additional production facilities in 28
countries, almost all in Europe and the Americas. It employs 6,700 people in its
subsidiaries with a further 4,800 employed in joint ventures. Sales in the year
to 31 March 2004 totalled £3,167 million. More details are available on this
website www.tateandlyle.com.

SPLENDA(R) is a trademark of McNeil Nutritionals, LLC